Seeking Alpha

Dean Morel

 
View Dean Morel's StockTalks BY TICKER:
  • Dean Morel
    Huge day for Biota Feb 5th as GSK report Relenza sales and more importantly should provide guidance on plans to ramp production to 190M+
    2/3/10
    Reply
      • Dean Morel
        Biota Holdings, BTA.AX. Royalties from GSK sales of Relenza should be $A20-30M last Q. Could easily earn EV of $160M in the next 1.5 years.
        7/14/09
        Reply
          • Dean Morel
            Hunter Hall International Limited. Australian, undervalued, ethical fund manager, with excellent growth.
            6/25/09
            Reply